PADAMOLOGY LIBRARY
Published Research
Practical insights on medical monitoring, patient safety, trial execution, and the decisions that shape early oncology development.
Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer
A Phase II trial evaluating pembrolizumab and enobosarm in androgen receptor-positive metastatic triple-negative breast cancer.